Press Releases

  RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 10, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will host a virtual Investor Day on

Proceeds from offering, in combination with recent financing activity, extends cash runway into 2024 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 1, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 26, 2021-- TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 26, 2021-- TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it

The Intelligent Surgical Unit TM Enables Augmented Intelligence on the Senhance Ⓡ Surgical System RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 19, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to

Proceeds from offering, in combination with recent financing activity, extends cash runway into the fourth quarter of 2022 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 14, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 12, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into securities purchase

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 6, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a preliminary 2020 year-end corporate update.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 4, 2021-- TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando , President and Chief Executive Officer, and Shameze Rampertab , Executive Vice President and Chief Financial Officer, will present at two upcoming virtual

Represents the Third Senhance Surgical Program Initiated in Louisiana RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Dec. 17, 2020-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive